Table 6.
Predictors of mortality and intensive care admission in COVID-19 patients with pulmonary fibrosis.
| ICU admission | Mortality | |||||
| Predictors | HR | 95% CI | P-value | HR | 95% CI | P-value |
| Age | 1.0 | 0.9–1.2 | .742 | 1.0 | 0.9–1.4 | .107 |
| Sex | 1.1 | 0.5–1.9 | .877 | 1.1 | 0.2–3.2 | .844 |
| Smoking | 1.5 | 1.0–2.1 | .026∗ | 2.8 | 1.6–4.9 | <.001∗ |
| Comorbidities | ||||||
| Hypertension | 1.4 | 0.6–2.9 | .433 | 2.7 | 0.9–5.7 | .089 |
| Diabetes | 1.8 | 0.3–2.8 | .071 | 1.1 | 0.4–2.5 | .954 |
| Cardiovascular disease | 1.3 | 0.4–4.3 | .590 | 1.0 | 0.3–1.7 | .112 |
| Kidney disease | 1.5 | 0.3–8.4 | .657 | 2.5 | 0.6–3.1 | .392 |
| Obesity | 1.2 | 0.6–2.4 | .517 | 1.1 | 1.0–1.2 | .012∗ |
| Asthma | 2.7 | 1.1–6.7 | .033∗ | 3.1 | 1.0–9.4 | .001∗ |
| Associated complications | ||||||
| Sepsis | 2.2 | 0.4–2.9 | .089 | 2.3 | 1.2–4.7 | .017∗ |
| Acute kidney injury | 3.2 | 1.6–6.8 | .001∗ | 4.7 | 2.2–9.9 | .001∗ |